SELECT semaglutide to improve outcomes in patients with obesity and cardiovascular disease, also without diabetes

被引：0
|
作者：
Gajos, Grzegorz [1 ,2 ]
机构：
[1] Jagiellonian Univ Med Coll, Inst Cardiol, Dept Coronary Artery Dis & Heart Failure, Krakow, Poland
[2] St John Paul II Hosp, Krakow, Poland
来源：
CARDIOLOGY JOURNAL | 2024年 / 31卷 / 05期
关键词：
D O I：
10.5603/cj.102158
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：782 / 783
页数：2
相关论文
共 50 条
  • [31] Exploratory mediation analysis of the effect of semaglutide on cardiovascular outcomes in people with overweight or obesity in the SELECT randomised trial
    Colhoun, H.
    Lincoff, A. M.
    Linder, M.
    Hardt-Lindberg, S.
    Hovingh, G. K.
    Kahn, S.
    Kalayci Oral, T.
    Lingvay, I.
    Plutzky, J.
    Ryan, D. H.
    Weeke, P. E.
    Deanfield, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few
    Liuzzo, Giovanna
    Patrono, Carlo
    EUROPEAN HEART JOURNAL, 2024, 45 (08) : 570 - 571
  • [33] SELECT shows cardiovascular risk reduction with weight-loss drug semaglutide in people without diabetes
    Fernandez-Ruiz, Irene
    NATURE REVIEWS CARDIOLOGY, 2024, 21 (02) : 69 - 69
  • [34] SELECT shows cardiovascular risk reduction with weight-loss drug semaglutide in people without diabetes
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2024, 21 : 69 - 69
  • [35] Effect of Semaglutide in Individuals With Obesity or Overweight Without Diabetes
    Alanazi, Mokhlef
    Alshahrani, Jaber Abdullah
    Aljaberi, Ahmed Sulayman
    Alqahtani, Basel Ali A.
    Muammer, Mahdi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [36] Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity
    Carretero-Gomez, J.
    Carrasco-Sanchez, F. J.
    Fernandez-Rodriguez, J. M.
    Casado-Escribano, P.
    Miramontes-Gonzalez, J. P.
    Segui-Ripoll, J. M.
    Ena, J.
    Arevalo-Lorido, J. C.
    REVISTA CLINICA ESPANOLA, 2023, 223 (03): : 134 - 143
  • [37] Cardiovascular effects of semaglutide in patients with HFpEF and obesity
    Dahm, Johannes B.
    AKTUELLE KARDIOLOGIE, 2024, 13 (01) : 18 - 18
  • [38] Semaglutide Improved Cardiovascular Health in People Without Diabetes
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (23): : 2241 - 2242
  • [39] Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
    Verma, Subodh
    Emerson, Scott
    Plutzky, Jorge
    Kahn, Steven E.
    Stensen, Signe
    Weeke, Peter E.
    Musinga, Derrick
    Poirier, Paul
    Lingvay, Ildiko
    Lincoff, A. Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (05) : 541 - 545
  • [40] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Zweck, Elric
    Westenfeld, Ralf
    Szendroedi, Julia
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2075 - 2076
12345